haptoglobine est significativement plus élevée que dans le groupe des AJG C4d-(0,1 g/L versus 1, pp.45-52 ,
Thrombotic Microangiopathies, New England Journal of Medicine, vol.347, issue.8, pp.589-600, 2002. ,
DOI : 10.1056/NEJMra020528
Thrombotic microangiopathies, Seminars in Arthritis and Rheumatism, vol.43, issue.6, pp.797-805, 2014. ,
DOI : 10.1016/j.semarthrit.2013.11.004
Syndromes of Thrombotic Microangiopathy, New England Journal of Medicine, vol.371, issue.7, pp.1847-1895, 2014. ,
DOI : 10.1056/NEJMra1312353
The complement system, Cell and Tissue Research, vol.44, issue.16, pp.227-262, 2011. ,
DOI : 10.1007/s00441-010-1034-0
De Novo Thrombotic Microangiopathy After Kidney Transplantation: Clinical Features, Treatment, and Long-Term Patient and Graft Survival, Transplantation Proceedings, vol.44, issue.8, pp.2388-90, 2012. ,
DOI : 10.1016/j.transproceed.2012.07.039
Atlas de pathologie rénale, Ed Médecine Sciences Flammarion, pp.427-62, 2008. ,
Complement and its role in innate and adaptive immune responses, Cell Research, vol.71, issue.1, pp.34-50, 2010. ,
DOI : 10.1146/annurev.immunol.15.1.649
First of two parts, N Engl J Med, vol.5344, issue.14, pp.1058-66, 2001. ,
Second of two parts, N Engl J Med, vol.12344, issue.15, pp.1140-1184, 2001. ,
Pros and cons for C4d as a biomarker, Kidney International, vol.81, issue.7, pp.628-667, 2012. ,
DOI : 10.1038/ki.2011.497
Complement factor I in health and disease, Molecular Immunology, vol.48, issue.14, pp.1611-1631, 2011. ,
DOI : 10.1016/j.molimm.2011.04.004
Mechanisms of complement activation, C4d deposition, and their contribution to the pathogenesis of antibody-mediated rejection, Transplantation Reviews, vol.23, issue.3 ,
DOI : 10.1016/j.trre.2009.02.005
The Importance of C4d in Biopsies of Kidney Transplant Recipients, Clinical and Developmental Immunology, vol.12, issue.3, p.678180, 2013. ,
DOI : 10.1111/j.1600-6143.2011.03757.x
Complement: a key system for immune surveillance and homeostasis, Nature Immunology, vol.632, issue.9, pp.785-97, 2011. ,
DOI : 10.1038/nature07205
Mannose-binding lectin and the kidney, Nephrology Dialysis Transplantation, vol.22, issue.12, pp.3370-77, 2007. ,
DOI : 10.1093/ndt/gfm524
Complement and the kidney: What the nephrologist needs to know in 2006?, Nephrology Dialysis Transplantation, vol.20, issue.12, pp.2613-2632, 2005. ,
DOI : 10.1093/ndt/gfi166
Kidney transplants, antibodies and rejection: is C4d a magic marker?, Nephrology Dialysis Transplantation, vol.18, issue.11, pp.2232-2271, 2003. ,
DOI : 10.1093/ndt/gfg304
Diagnosis and Management of Antibody-Mediated Rejection: Current Status and Novel Approaches, American Journal of Transplantation, vol.2012, issue.5 Pt 1, pp.255-71, 2014. ,
DOI : 10.1111/ajt.12589
Capillary Deposition of Complement Split Product C4d in Renal Allografts is Associated with Basement Membrane Injury in Peritubular and Glomerular Capillaries: A Contribution of Humoral Immunity to Chronic Allograft Rejection, Journal of the American Society of Nephrology, vol.13, issue.9, pp.2371-80, 2002. ,
DOI : 10.1097/01.ASN.0000025780.03790.0F
Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions, American Journal of Transplantation, vol.17, issue.2, pp.272-83, 2014. ,
DOI : 10.1111/ajt.12590
C4d staining of renal allograft biopsies: a comparative analysis of different staining techniques, Nephrology Dialysis Transplantation, vol.22, issue.2, pp.568-76, 2007. ,
DOI : 10.1093/ndt/gfl594
Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions, American Journal of Transplantation, vol.23, issue.4 ,
DOI : 10.1046/j.1523-1755.1999.00299.x
Analysis of Different Staining Techniques for C4d Detection in Renal Allograft Biopsies, Transplantation Proceedings, vol.41, issue.3 ,
DOI : 10.1016/j.transproceed.2009.01.073
Banff 07 Classification of Renal Allograft Pathology: Updates and Future Directions, American Journal of Transplantation, vol.23, issue.4 ,
DOI : 10.1046/j.1523-1755.1999.00299.x
Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection, Nephrology Dialysis Transplantation, vol.16, issue.10, pp.2058-66, 2001. ,
DOI : 10.1093/ndt/16.10.2058
Classical pathway of complement activation in normal and diseased human glomeruli, Kidney International, vol.36, issue.6, pp.1069-77, 1989. ,
DOI : 10.1038/ki.1989.302
Association between anti-beta2 glycoprotein I antibodies and renal glomerular C4d deposition in lupus nephritis patients with glomerular microthrombosis: a prospective study of 155 cases ,
STEC-HUS, atypical HUS and TTP are all diseases of complement activation, Nature Reviews Nephrology, vol.46, issue.11, pp.622-655, 2012. ,
DOI : 10.1038/nrneph.2012.195
Eculizumab in the treatment of refractory idiopathic thrombotic thrombocytopenic purpura, British Journal of Haematology, vol.26, issue.6, pp.772-74, 2012. ,
DOI : 10.1111/j.1365-2141.2012.09084.x
Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritis, Arthritis & Rheumatism, vol.114, issue.8, pp.2460-69, 2008. ,
DOI : 10.1002/art.23662
Glomerular C4d Deposition Indicates in situ Classic Complement Pathway Activation, but is not a Marker for Lupus Nephritis Activity, Yonsei Medical Journal, vol.44, issue.1 ,
DOI : 10.3349/ymj.2003.44.1.75
Thrombotic Microangiopathy After Kidney Transplantation, American Journal of Transplantation, vol.9, issue.7 ,
DOI : 10.1111/j.1600-6143.2010.03156.x
Therapeutic potential of complement modulation, Nature Reviews Drug Discovery, vol.59, issue.1, pp.43-56, 2010. ,
DOI : 10.1038/nrd3011
Eculizumab for paroxysmal nocturnal haemoglobinuria, The Lancet, vol.373, issue.9665, pp.759-67, 2009. ,
DOI : 10.1016/S0140-6736(09)60001-5
Treatment of Atypical Hemolytic Uremic Syndrome and Thrombotic Microangiopathies: A Focus on Eculizumab, American Journal of Kidney Diseases, vol.61, issue.2, pp.289-99, 2013. ,
DOI : 10.1053/j.ajkd.2012.07.028
Eculizumab: A Review of Its Use in Atypical Haemolytic Uraemic Syndrome, Drugs, vol.26, issue.8, pp.2053-66, 2013. ,
DOI : 10.1007/s40265-013-0147-7
Complement Factor C4d Is a Common Denominator in Thrombotic Microangiopathy, Journal of the American Society of Nephrology, vol.26, issue.9, pp.2239-2286, 2015. ,
DOI : 10.1681/ASN.2014050429
Etude de la fixation glomérulaire de l'anticorps anti-C4d en pathologie du greffon rénal, Thèse de doctorat en médecine, sous la direction du Pr Guy Touchard, pp.27-2014 ,
Cancer-Related Microangiopathic Hemolytic Anemia, Medicine, vol.91, issue.4, pp.195-205, 2012. ,
DOI : 10.1097/MD.0b013e3182603598
Thrombotic Microangiopathy, Cancer, and Cancer Drugs, American Journal of Kidney Diseases, vol.66, issue.5, pp.272-6386, 2015. ,
DOI : 10.1053/j.ajkd.2015.02.340
Patients with localized and disseminated tumors have reduced but measurable levels of ADAMTS- 13 (von Willebrand factor cleaving protease, Haematologica, vol.88, issue.4, pp.454-58, 2003. ,
Abnormalities of von willebrand factor multimers in drug-associated thrombotic microangiopathies, American Journal of Hematology, vol.74, issue.3, pp.268-77, 1993. ,
DOI : 10.1002/ajh.2830420306
9A.09, Journal of Hypertension, vol.33, issue.1, p.119, 2015. ,
DOI : 10.1097/01.hjh.0000467672.93812.38
Complement and coagulation: strangers or partners in crime? Trends Immunol, pp.184-92, 2007. ,
A novel C5a receptortissue factor cross-talk in neutrophils links innate immunity to coagulation pathways ,
Simultaneous Activation of Complement and Coagulation by MBL-Associated Serine Protease 2, PLoS ONE, vol.C, issue.7, p.623, 2007. ,
DOI : 10.1371/journal.pone.0000623.g005
Platelets and the complement cascade in atherosclerosis, Frontiers in Physiology, vol.21, issue.294, p.49, 2015. ,
DOI : 10.1161/hq0701.092160
Platelet C4d is highly specific for systemic lupus erythematosus, Arthritis & Rheumatism, vol.10, issue.2, pp.670-74, 2006. ,
DOI : 10.1002/art.21627
Terminal Complement Components Mediate Release of von Willebrand Factor and Adhesion of Platelets in Arteries of Allografts, Transplantation, vol.79, issue.3, pp.276-81, 2005. ,
DOI : 10.1097/01.TP.0000146195.76904.D3